PCMA President Mark Merritt Testifies Before HELP Committee

PCMA President and CEO Mark Merritt Highlights PBM Solutions to Address the Opioid Crisis

PCMA Issues Guiding Principles, Policy Solutions to HHS on Reducing Prescription Drug Costs

Pharma Price Increases Not Correlated with Rebates

Drug Benefit Solutions

PBMs reduce costs & generate savings


Various medicine pills and capsules in plastic container

Drug Cost Management

Over the next ten years, PBMs and specialty pharmacies will save payers and patients an estimated total of $250 billion on the cost of specialty medications and related non-drug medical costs when compared to what expenditures would be with limited use of PBMs and specialty pharmacies.

Learn More

Drug Coupons & Assistance Programs

Learn More

Fraud, Waste & Abuse

Learn More

Value & Outcome-Based Contracting

Learn More

Drug Coverage Mandates

Learn More

Pharmacy Contracting & Reimbursement

Learn More

Drug Abuse Prevention

Learn More


PCMA hosts three annual events: the sPCMA Business Forum, the PBM Policy Forum, and the PCMA Annual Meeting

PCMA’s conference brand is known for bringing together thought leaders and pharmacy benefit decision makers from PBMs, specialty pharmacies, and pharma and biotech manufacturers.

Learn More




PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.

Stay Connected with PCMA!